Adam Amara

Adam Amara is a co-founder at Turing Biosystems, focusing on enhancing patient therapies through a proprietary software and hardware platform that utilizes advanced AI and real-world data insights. Prior experience includes serving as a research fellow at the International Agency for Research on Cancer/World Health Organization, where Adam led the development of a computational framework for analyzing metabolomics and multi-omics data in cancer studies. As vice-chair of the European Synthetic Biology Society, Adam contributed to the growth of the organization while engaging in entrepreneurial activities in the role of Entrepreneurship Officer. Adam's academic background includes a PhD in Synthetic and Systems Biology from the University of Manchester, where research centered on metabolomics and synthetic biology for therapeutic compound production. Adam also holds a BSc in Biochemistry from the same institution.